The Sigma 17-40mm F1.8 was one of our favorite lenses in a year of great lenses. Photo: Mitchell Clark We recently argued ...

As 2025 comes to a close, we're looking back at what happened this past year. We've already shared our favorite gear and photos, but now let's zoom out and look at the bigger picture: the numbers and ...

Almost like it was a competition to see who could bring the most new stuff to the party at the IBC expo in Amsterdam, Venus ...

The first round of our Readers' Choice voting is complete. Find out which products won the Best Camera, Best Prime Lens and ...

Scott Nevil is an experienced writer and editor with a demonstrated history of publishing content for Investopedia. He goes in-depth to create informative and actionable content around monetary policy ...

A first look at Canon-powered Vaonis Hyperia – a smart telescope that brings professional observatory-level astrophotography ...

2025 started off with a bang, with the release of the Leica SL3-S – a full frame camera focused on speed, rather than resolution – and our review of the Nikon Z50II, an entry level APS-C camera ...

Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...

The traditional full line pharmacy wholesale distribution business, retail and private label products. Also has national Presence in the hospital pharmacy distribution market, and through its network ...

Sigma CR150 is a High Flex knee system designed to combine function with wear resistance. As the name denotes, Sigma CR150 implant system accommodates up to 150 degrees of flexion while preserving the ...

HIGHS Massively capable off-road, two tenacious engines, docile on the pavement. LOWS Mortgage-like monthly gas bill, V-8 moves the price up a tax bracket, makes normal parking spots feel miniature.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.